Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2025-04-30 Report Publication Anno…
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel
Report Publication Announcement Classification · 99% confidence The document is titled "Mise à disposition du Rapport Financier Annuel 2024" (Making available of the 2024 Annual Financial Report). It explicitly states that the company has made available and filed its Annual Financial Report for the year ended December 31, 2024, with the AMF (French regulator) on April 30, 2025. Crucially, the document itself is an announcement *about* the availability of the report, not the full report (10-K or AR). The document length is short (4440 characters) and it directs the reader to the company website or the AMF site to consult or download the actual report. This perfectly matches the definition of a Report Publication Announcement (RPA), which is used when a document announces the release of another report, adhering to the 'MENU VS MEAL' rule.
2025-04-30 French
Inside Information / Other news releases
Investor Presentation Classification · 99% confidence The document is titled with a date and announces company activities related to an upcoming conference ('Digestive Disease Week® 2025'). It uses language typical of a press release, such as 'Mauna Kea Technologies Announces...', includes executive quotes, and concludes with standard sections like 'About [Company]' and 'Disclaimer'. This format strongly indicates an Earnings Release (ER) or a general press release announcing business updates, rather than a formal regulatory filing like a 10-K, IR, or a specific report attachment (RPA). Since it is announcing business milestones and upcoming conference participation, and not explicitly detailing quarterly financial results (which would lean towards ER), it fits best as a general corporate announcement. However, given the options, announcements of business progress and participation in industry events are often categorized under Earnings Release (ER) if they are periodic updates, or Regulatory Filings (RNS) if they are general news. Since it is a formal announcement dated April 28, 2025, detailing future events and scientific presentations, it functions as a corporate update. In the absence of explicit financial figures, it is most closely aligned with a general press release announcing corporate news, which often defaults to RNS if ER is reserved strictly for financial performance summaries. Given the context of financial reporting databases, announcements of significant business milestones and conference participation are frequently classified as Earnings Releases (ER) or Investor Presentations (IP). Since this is a press release format, ER is the most appropriate fit among the specific options for non-financial-statement updates, though RNS is a possibility. I will classify it as ER as it serves as a periodic update on company progress.
2025-04-28 English
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 99% confidence The document is a press release dated April 28, 2025, announcing that Mauna Kea Technologies will present 8 abstracts demonstrating the clinical value of its Cellvizio® platform at the Digestive Disease Week® (DDW) conference. It details the topics of the presentations (pancreatic cysts, AI, food intolerances) and includes quotes from the CEO. This type of announcement, detailing upcoming scientific presentations or participation in a major industry event, is typically classified as an Investor Presentation (IP) if it were the presentation itself, or an Earnings Release (ER) if it contained financial results. Since this document is an announcement about scientific/clinical data presentation at a conference, and not a formal financial report (10-K, IR, ER), it best fits the 'Investor Presentation' category as it is material intended for investors and the medical community regarding product validation and future prospects, or potentially a Regulatory Filing (RNS) if it were purely informational. Given the focus on scientific validation and future opportunities discussed with investors/partners, 'Investor Presentation' (IP) is the most appropriate fit among the specific options, as it is promotional/informational material aimed at stakeholders about clinical progress, even though it's structured as a press release. It is not a formal financial report, a management discussion, or a simple dividend/share change notice. It is an announcement of scientific findings being presented, which often accompanies or precedes investor materials.
2025-04-28 French
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 100% confidence The document is titled "Mauna Kea Technologies annonce ses résultats pour l'année 2024 et fait le point sur son activité" and contains detailed financial tables for the year 2024 compared to 2023, including Revenue, Gross Margin, EBITDA, and Net Income. It explicitly states it is publishing its financial results for the year 2024. This strongly indicates an Annual Report (10-K) or a comprehensive Interim/Quarterly Report (IR). Since the reporting period is the full year ('l'année 2024') and it includes detailed consolidated financial statements (Compte de résultat consolidé), it aligns best with the scope of an Annual Report (10-K), even if it is presented as a press release summarizing the findings. However, given the context of financial reporting, a full-year report that is not explicitly labeled as a 10-K filing but contains the full annual results is often classified as the closest equivalent or sometimes as an Earnings Release (ER) if it were just highlights. Because this document contains detailed financial breakdowns, management discussion, and covers the full fiscal year, it is more comprehensive than a typical ER. Since the document is a detailed announcement of annual results, and the length (22,858 chars) suggests comprehensive content, it is classified as the primary annual financial disclosure. If a specific 10-K filing document were not available, this comprehensive annual results announcement serves as the primary source for annual performance, making '10-K' the most appropriate category for the underlying information type, although 'ER' (Earnings Release) is also plausible for the *format* of this specific announcement. Given the depth of the financial data provided (full year results, detailed P&L), it surpasses a simple ER. I will classify it as 10-K as it represents the full annual performance disclosure. FY 2024
2025-04-24 French
Inside Information / News release on accounts, results
Earnings Release Classification · 100% confidence The document is titled "Mauna Kea Technologies Reports Full Year 2024 Results and Provides a Business Update" and contains detailed consolidated financial statements, including an income statement for FY 2024 vs FY 2023, operational highlights, management commentary on performance, and outlook. The presence of comprehensive, audited (or in process of being audited) financial tables covering a full fiscal year strongly indicates an Annual Report or a document closely related to it. Since it reports full-year results and includes detailed financial statements, it aligns best with the scope of a comprehensive annual filing. Although it is presented as a press release format, the depth of financial data provided (including the full income statement) suggests it is the primary release of the Annual Report data, which often precedes or is synonymous with the 10-K filing in terms of content disclosure. Given the options, '10-K' (Annual Report) is the most appropriate classification for a comprehensive full-year financial disclosure, even if it's an earnings release format, because the content is the full annual performance review. If this were a quarterly report, 'IR' would be used. Since it is the full year, '10-K' is selected. FY 2024
2025-04-24 English
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Monthly information regarding the total number of voting rights and shares comprising the share capital" and explicitly references French regulatory articles (Commercial Code, AMF General Regulations). It provides a table detailing the number of shares and voting rights as of March 31, 2025. This type of regular disclosure concerning the total share capital and voting rights structure is a specific regulatory requirement, often related to major shareholding notifications or capital structure updates. Given the options, it most closely aligns with reporting changes in share capital or significant ownership structure, which falls under Major Shareholding Notification (MRQ) or potentially Share Issue/Capital Change (SHA). However, since it is a monthly update on the *total* number of rights and shares, and not necessarily a notification of a specific transaction crossing a threshold (MRQ) or a new issue (SHA), it represents a routine disclosure about the capital base. In many jurisdictions, these monthly updates are treated as general regulatory disclosures. Since it is a specific, recurring regulatory disclosure that doesn't fit perfectly into the other specific categories (like ER, 10-K, DIV), and it is a formal announcement, it is best classified as a Regulatory Filing (RNS) as a specific regulatory disclosure fallback, although MRQ is a close second if the context implied crossing a threshold. Given the structure and content (monthly capital count), RNS is the most appropriate general regulatory filing category when a more specific one like MRQ (which usually implies a threshold breach) is not explicitly confirmed.
2025-04-07 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.